ANTIDIABETIC DRUG APPROVED TO REDUCE RISK OF KIDNEY DISEASE

被引：0

|

作者：

Aschenbrenner, Diane S. ^{[1
,2
]}

机构：

[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA

[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA

来源：

AMERICAN JOURNAL OF NURSING | 2021年 / 121卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：25 / 25

页数：1

相关论文

共 50 条

[1] Kidney transplant drug approved
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (15) : 1372 - 1372
[2] Treating chronic kidney disease to reduce cardiovascular risk
Cice, Gennaro
Monzo, Luca
Calo, Leonardo
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 (SUPPB) : B50 - B54
[3] Amyloid disease drug approved
Ken Garber
Nature Biotechnology, 2012, 30 (2) : 121 - 121
[4] Pioglitazone:: an antidiabetic drug with the potency to reduce cardiovascular mortality
Pfützner, A
Forst, T
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (04) : 463 - 476
[5] Scrubbed plasma approved to reduce disease transmission
Ault, A
LANCET, 1998, 351 (9114): : 1494 - 1494
[6] Treating the patient with kidney failure to reduce cardiovascular disease risk
Menon V.
Sarnak M.
Current Treatment Options in Cardiovascular Medicine, 2004, 6 (4) : 257 - 268
[7] FDA Approves Semaglutide to Reduce Risk of Kidney Disease Progression
Anderer, Samantha
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (13):
[8] New Drug Approved for Alzheimer Disease
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2024, 124 (11) : 18 - 19
[9] Drug Approved for Rare Lung Disease
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (01): : 17 - 17
[10] FDA approves canaglifl ozin to reduce risk of diabetic kidney disease
不详
NURSE PRACTITIONER, 2020, 45 (02): : 56 - 56

← 1 2 3 4 5 →